Skip to main content

Advertisement

Table 5 Clinical Outcome of diabetes subjects based on MAGE levels during in-hospital and 30-day follow-up

From: Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions

MAGE (mmol/L)   <2.84 2.84-3.96 >3.96 P
Subject number (n) 73 24 24 25 NA
Composite MACE 18 (24.7) 2 (8.3) 6 (25) 10 (40) 0.038
Non-IRA revascularization 27 (37) 4 (15) 10 (21) 13 (32) 0.032
  1. Data given as n (%).
  2. MAGE, the mean amplitude of glycemic excursions; MACE, major adverse cardiac events; TVR, target vessel revascularization; IRA, infarct related arteries.